| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 07/29/2004 | US20040146904 Vascular-preferred promoter sequences and uses thereof |
| 07/29/2004 | US20040146892 Expression vector coding organelle transport protein for use in identifying modulators of adenine nucleotide translocator and cyclophilin d interaction |
| 07/29/2004 | US20040146889 Inducible regulatory system and use thereof |
| 07/29/2004 | US20040146888 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 07/29/2004 | US20040146882 Human acid sensing ion channel 2b (hASIC2b), process for producing the same, and its use |
| 07/29/2004 | US20040146877 Diagnosis and treatment of cancer:I |
| 07/29/2004 | US20040146872 Comprises nucleotide sequences coding delta-2-enoyl-coA isomerase for use in identifying modulators for treatment and diagnosis of inflammatory, cardiovascular, skin, body weight and cancer disorders |
| 07/29/2004 | US20040146865 Use of haploid genomes for genetic diagnosis, modification and multiplication |
| 07/29/2004 | US20040146854 Attenuated forms of bovine viral diarrhea virus |
| 07/29/2004 | US20040146846 Storage and maintenance of blood products including red blood cells and platelets |
| 07/29/2004 | US20040146525 Shellfish protein |
| 07/29/2004 | US20040146519 For use in vaccines, prophylaxis and therapy of cancer |
| 07/29/2004 | US20040146513 Monoclonal antibodies against human protein Mcm3, process for their production, and their use |
| 07/29/2004 | US20040146506 Antibodies specific for a cell surface molecule mediating cell adhesion and signal transmission, cells secreting such antibodies, and methods of making and using such antibodies |
| 07/29/2004 | US20040146504 Anti-IgE vaccines |
| 07/29/2004 | US20040146492 Methods and compositions for transforming dendritic cells and activating T cells |
| 07/29/2004 | US20040146488 Gene expression of protein with ability to chaperon antigenic peptides of tumor cells to antigen-presenting cells (APCs); selective replication in and killilng of tumor cells; immunotherapy; antimetastasis and anticarcinogenic agents |
| 07/29/2004 | US20040146459 Renal nuclear matrix proteins, polynucleotide sequences encoding them, and their use |
| 07/29/2004 | DE10045016B4 Retrovirale Vektoren mit Fremdsequenzinsertion zwischen retroviraler Primerbindungsstelle und retroviralem Spleißdonor Retroviral vectors with Fremdsequenzinsertion between retroviral primer binding site and retroviral splice donor |
| 07/29/2004 | CA2513337A1 Use of retinoic esters of hyaluronic acid for the differentiation of totipotent stem cells |
| 07/29/2004 | CA2513226A1 Persistent expression of candidate molecule in proliferating stem and progenitor cells for delivery of therapeutic products |
| 07/29/2004 | CA2512717A1 Compositions and methods for targeted biological delivery of molecular carriers |
| 07/29/2004 | CA2512673A1 2-o sulfatase compositions and related methods |
| 07/28/2004 | EP1441029A1 Human cell lines |
| 07/28/2004 | EP1441028A2 Cell cultivation method for the preparation of chondrocytes/chondroblasts |
| 07/28/2004 | EP1440982A2 Ifn-thy fusion protein, dna coding therefore, its preparation and application |
| 07/28/2004 | EP1440163A2 Methods and compositions for the treatment and diagnosis of pain disorders using 46566 |
| 07/28/2004 | EP1440157A1 Methods and means for producing proteins with predetermined post-translational modifications |
| 07/28/2004 | EP1440155A2 Lipase variants |
| 07/28/2004 | EP1440150A2 Pyranosone dehydratase from phanerochaete chrysosporium |
| 07/28/2004 | EP1440148A2 Keratinocytes which may be used as biologically active substances for the treatment of wounds |
| 07/28/2004 | EP1440147A2 Method for enhancing keratinocyte stem cells |
| 07/28/2004 | EP1440143A1 Device with recessed tracks for forming a cellular network |
| 07/28/2004 | EP1440091A1 Nogo receptor homologues and their use |
| 07/28/2004 | EP1440085A2 Transient immortalization of cells by oncogenic proteins or telomerase |
| 07/28/2004 | EP1440084A2 Sperm factor sequences |
| 07/28/2004 | EP1440083A2 Molecules |
| 07/28/2004 | EP1439897A2 Methods, compositions, and automated systems for separating rare cells from fluid samples |
| 07/28/2004 | EP1439864A2 Methods for the treatment and diagnosis of tumorigenic and angiogenic disorders using 32616 |
| 07/28/2004 | EP1439863A2 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism |
| 07/28/2004 | EP1439861A2 Methods and kits for use in selecting approaches to treating cancer |
| 07/28/2004 | EP1439852A1 Peptides and related compounds having thrombopoietic activity |
| 07/28/2004 | EP1392111A4 Method for targeting transcriptionally active loci |
| 07/28/2004 | EP1289575B1 Method for producing a recipient-specific tissue transplant |
| 07/28/2004 | EP1238095A4 Compositions and methods for caspase-induced apoptosis |
| 07/28/2004 | EP1226244B1 Polypeptides with non-natural primary signalling motifs |
| 07/28/2004 | EP0936930B1 Myocardial graft constructs |
| 07/28/2004 | EP0912741B1 T-cell selective interleukin-4 agonists |
| 07/28/2004 | EP0728214B1 Stable cell lines capable of expressing the adeno-associated virus replication gene |
| 07/28/2004 | EP0719332B1 Monocyte macrophage line recombinant cells for gene therapy |
| 07/28/2004 | EP0452484B2 Production of proteins using homologous recombination |
| 07/28/2004 | CN1516739A Use of HMG fragments as anti-inflammatory agents |
| 07/28/2004 | CN1516736A Transgenic plants with reduced adenylate kinase activity showing increased accumulation of starch |
| 07/28/2004 | CN1516734A Transformed silkworm producing human collagen |
| 07/28/2004 | CN1516706A Endogenous and non-endogenous versions of human G protein-coupled receptors |
| 07/28/2004 | CN1515672A Human chemotactic factor beta-8, chemotactic factor beta-1 and macrophage inflammatory protein-4 |
| 07/28/2004 | CN1515671A Agrobacterium mediated plant nonselective gene conversion and nonselective marker gene conversion method |
| 07/28/2004 | CN1159584C Method and medicine box of testing anti-hepatitis C virus antibody |
| 07/28/2004 | CN1159455C Detection of DNA, RNA and proteins |
| 07/28/2004 | CN1159440C Mutants of Rb and p53 genes and uses thereof |
| 07/28/2004 | CN1159439C Pantropic neurotrophic factors |
| 07/28/2004 | CN1158916C Method for mass producing clonal plant seedling belonging to eucalyptus woodly plant |
| 07/27/2004 | US6768001 Xylanase from trichoderma reesei, method for production thereof, and methods employing this enzyme |
| 07/27/2004 | US6767997 Antibodies that bind deoxyribonuclease IIβ enzyme proteins |
| 07/27/2004 | US6767741 Metal binding compounds and their use in cell culture medium compositions |
| 07/27/2004 | US6767740 Stem cell and dental pulp harvesting method and apparatus |
| 07/27/2004 | US6767738 Repairing damaged or diseased, specialized or differentiated tissue in mature animals, like neuronal tissue such as retinas transplantation of adult, hippocampus-derived progenitor cells into a selected neural tissue site of a recipient |
| 07/27/2004 | US6767737 Phenotype of stem cells which contain a fibroblast growth factor receptor (fgfr) on the cell surface thereof and further have a phenotype indicative of a primitive state |
| 07/27/2004 | US6767730 Enzymatic polypeptide for use in the treatment of cardiovascular asthma and dietitic disorders |
| 07/27/2004 | US6767721 Nucleotide sequences coding polypeptide for use in the treatment and prevention parasitic infections |
| 07/27/2004 | US6767712 Models of prion disease |
| 07/27/2004 | US6767711 Antibody, its binding portion or a probe is capable of binding to normal, benign, hyperplastic and cancerous epithelia cells and killing or ablating them; does not recognize antigens circulating in the blood |
| 07/27/2004 | US6767705 Recombinant expression construct encoding a reporter gene operably linked to a promoter from a gene the expression of which is induced by a retinoid, wherein the promoter does not contain a retinoic acid response elements site |
| 07/27/2004 | US6767700 Tumor cells having tumorigenic potential but lacking invasive/metastatic potential, method for preparing them and screening method for metastasis-related genes using the same |
| 07/27/2004 | CA2279999C The neurotrophic factor nnt-1 |
| 07/27/2004 | CA2069900C Dna segment encoding a gene for a receptor related to the epidermal growth factor receptor |
| 07/22/2004 | WO2004061092A1 Method of culturing pluripotent stem cells and culture apparatus therefor |
| 07/22/2004 | WO2004061091A2 Insulin producing cells |
| 07/22/2004 | WO2004061090A1 Composition capable of activating natural killer cells and process for producing the same, composition containing natural killer cells activated by the former composition and process for producing the same |
| 07/22/2004 | WO2004061089A1 Dendritic cell line |
| 07/22/2004 | WO2004061079A2 Candida kefyr cytosine deaminase |
| 07/22/2004 | WO2004061077A2 Increasing gamete production with a gene switch |
| 07/22/2004 | WO2004061073A2 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 07/22/2004 | WO2004060869A2 Methods and compositions for catalytic dna exchange in a sequence manner |
| 07/22/2004 | WO2004060426A1 Engineered scaffolds for promoting growth of cells |
| 07/22/2004 | WO2004060145A2 Isolation and identification of cross-reactive t cells |
| 07/22/2004 | WO2004060053A2 Transgenic mice expressing human cd20 |
| 07/22/2004 | WO2004060052A2 Transgenic mice expressing human cd20 and/or cd16 |
| 07/22/2004 | WO2004046712A3 Isolation of sperm cells from other biological materials using microfabricated devices and related methods thereof |
| 07/22/2004 | WO2004037969A3 Advanced roller bottle system for cell and tissue culturing |
| 07/22/2004 | WO2004031367A3 Uses of human zven proteins and polynucleotides |
| 07/22/2004 | WO2004029229A3 Methods for promoting dopaminergic neuronal development by using ng4a-subfamily and wnt-ligands |
| 07/22/2004 | WO2004028554A3 Skrp, astray, string, vacm associated with metabolic control |
| 07/22/2004 | WO2004024938A3 Β1,4-n-acetylgalactosaminyltransferases, nucleic acids and methods of use thereof |
| 07/22/2004 | WO2004021977A3 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer |
| 07/22/2004 | WO2004009822A3 Use of specific myb genes for the production of transgenic plants tolerant to biotic and abiotic stresses |
| 07/22/2004 | WO2004007547A3 Truncated tau proteins |
| 07/22/2004 | WO2004005529A3 GEF-H1b: BIOMARKERS, COMPLEXES, ASSAYS AND THERAPEUTIC USES THEREOF |
| 07/22/2004 | WO2003106695A3 Methods and compositions for in vivo clearance of pathogens |
| 07/22/2004 | WO2003094965A3 Modulation of neural stem cells with s1p or lpa receptor agonists |